Brief: Marker Therapeutics Delivers Notice To Lincoln Park Capital Fund
01/03/2024 13:21
March 1 (Reuters) - Marker Therapeutics Inc MRKR.O :
* MARKER THERAPEUTICS INC - ON FEB 29 DELIVERED NOTICE TO
LINCOLN
PARK CAPITAL FUND, LLC TERMINATING PURCHASE AGREEMENT, DATED
DECEMBER 12, 2022
* MARKER THERAPEUTICS INC - PROJECTS A FINANCIAL RUNWAY
THROUGH Q4
OF 2025 AND DOES NOT ANTICIPATE AN IMMEDIATE NEED FOR CAPITAL
ACQUISITION
Source text for Eikon: ID:n0001104659-24-029638
Further company coverage: MRKR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marker Therapeutics
See all newsBrief: Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant To Advance MT-601 In Pancreatic Cancer
Marker Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Marker Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
Marker Therapeutics 2025 net loss widens, hurt by decline in grant income
Brief: Marker Therapeutics FY Basic EPS USD -0.79